EN
All Categories
EN

Q & A ad Sars Sinocare II-antibody test-Cov velit

Tempus: 2020, 05 08, hits: 160

1. Quam ut identify confirmata casibus?

Uno ex his casibus, et suspicio non etiological serological confirmari potest;

a. Verus-Tempus indicat fluorescent RT-PCR positivum pro novus coronavirus nucleic acidum,

b. De Viris Illustribus sequentia gene est scire novum illum homologum coronavirus

c. IgM propria virus Serum et in NCP sunt detectable Fusobacterium nucleatum; Fusobacterium nucleatum est propria virus NCP

detectable vel saltem spatia in IV de titratione j triplicem statuit incremento in remissione est comparari acutis Phase.

 

2. Quid est hoc si habent positivum test eventus?

If you have a positive test result, it is very likely that you have virus. Therefore, it is also likely that you may be placed in isolation to avoid spreading the virus to others. However, due to unknown source interference substances, the test result may still be positive which is called false-positive. Your healthcare provider will work with you to determine how best to care for you based on the test results along with other factors of your medical history, and your symptoms, possible exposures, and geographic location of places you have recently traveled.

 

3. Quid sibi vult Si negans habere test eventus?

A negative test result means that the antibody that caused by virus was not found in your sample. For virus, a negative test result for a sample collected while a person has symptoms usually means that virus did not cause your recent illness.

However, it is possible for this test to give a negative result that is incorrect (false negative) in some people with virus. This means that you could possibly still have virus even though the test is negative. If this is the case, your healthcare provider will consider the test result together with all other aspects of your medical history (such as symptoms, possible exposures, and geographical location of places you have recently traveled) in deciding how to care for you. It is important that you work with your healthcare provider to help you understand the next steps you should take.

 

4. Quid si ego hoc productum?

Currently, nucleic acidum est maxime plerumque adsuesco assuesco Diagnostic modum certaminis; sed ars est haec omnia expertus potuisset deprehendere virus portarent: tentantes cum maxime plerumque adsuesco assuesco exemplaria tractus respiratorii superioris. Quoniam confirmata casibus, interdum plures temptationis et probat per exempla multa sunt, ut consequeretur positivum praecessi. Et de hoc statu, quod in summo gradu suspected consequi atque obtinere non possunt aegris cum nucleic acidum positivum test results. Sunt quatuor rationes potentiale;

1) the viral loads in upper respiratory tract samples are much lower than that in lower respiratory tract samples in virus aegros

II) ad releasing onerat de aegris virales infectio per in gradu cuiusque pro diversis range sit lata;

III) summus quae est collectum quidquid fabrefieri potest qualis swab specimen requirit sanitas, opifices;

IV) PCR: reagentia, sunt alta nuntiorum ex variis discrepent.

Et super exitibus pose gravi obligatione de qua in opportune vita challenges-Praecaventur et curatio suscipio separati habeant. Ergo necesse est serological deprehendatur.

 

The specific clinical significance and value of serological detection for virus area follows:

1) for the suspected case of the first doctors' office visiting and the confirmed case with the clinical diagnosis but without viral nucleic acid testing, the positive results of antibody can be used as an aid in the diagnosis of virus;

II) ad proxima contactus cum sanus effectus antibody positivum, non possunt carriers Et haec cogitanda sunt, se habent in solitudine tempus observationis, amplio nucleic acidum frequency tentatio, crescat nucleic acidum est specimen genere temptationis, et auferte omnem contactu inquisitio;

3) patients tested by viral nucleic acid, serum antibody positive result indicates that specific immune response has been induced in body, which can help doctors to judge the connection between the body's immunity and the subsequent development of the patient's disease;

IV) serum propter quantitatis taxationem falciparum levels convalescent in aegris, inter quos falciparum princeps titer pro plasma potest adhiberi curatio gravibus de aegris,

5) combine with viral nucleic acid testing to identify potential virus carriers in key populations, such as travelers in outbreak countries or regions, participants in important meetings or events, and people returning to work or school. Isolate and monitoring the people with virus nucleic acid negative but antibody positive, in order to detect potential virus infection in time, reduce the transmission risk.